CRISPR Therapeutics
CRSP
CRSP
309 hedge funds and large institutions have $4B invested in CRISPR Therapeutics in 2020 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 96 increasing their positions, 86 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
309
Holders Change
+34
Holders Change %
+12.36%
% of All Funds
6.25%
Holding in Top 10
9
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+50%
% of All Funds
0.18%
New
69
Increased
96
Reduced
86
Closed
32
Calls
$64.7M
Puts
$66.4M
Net Calls
-$1.72M
Net Calls Change
+$10.2M
